154
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Histological response and expression of collagen, metalloproteinases MMP-1 and MMP-9 and tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2 in fetal membranes following open intrauterine surgery: an experimental study

, , , , , , , & show all
Pages 1301-1309 | Received 10 Oct 2019, Accepted 03 Apr 2020, Published online: 15 Apr 2020

References

  • Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med. 2011;364(11):993–989.
  • Moron A, Barbosa M, Milani H, et al. Short-term surgical and clinical outcomes with a novel method for open fetal surgery of myelomeningocele. Am J Obstet Gynecol. 2015;212(1):S374.
  • Rocker I, Laurence KM. Defect in fetal membranes after fetoscopy. Lancet. 1978;311(8066):716.
  • Borgida AF, Mills AA, Feldman DM, Rodis JF, et al. Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis. Am J Obstet Gynecol. 2000;183(4):937–939.
  • Quintero RA, Carreño CA, Yelian F, et al. Repair kinetics of amnion cells after microsurgical injury. Fetal Diagn Ther. 1996;11(5):348–356.
  • Bilic G, Ochsenbein-Kölble N, Hall H, et al. In vitro lesion repair by human amnion epithelial and mesenchymal cells. Am J Obstet Gynecol. 2004;190(1):87–92.
  • Devlieger R. Matrix metalloproteinases-2 and -9 and their endogenous tissue inhibitors in tissue remodeling after sealing of the fetal membranes in a sheep model of fetoscopic surgery. J Soc Gynecol Investig. 2002;9(3):137–145.
  • Devlieger R, A.Deprest J, Gratacós E, et al. Matrix metalloproteinases -2 and -9 and their endogenous tissue inhibitors in fetal membrane repair following fetoscopy in a rabbit model. Mol Hum Reprod. 2000;6(5):479–485.
  • Calvin SE, Oyen ML. Microstructure and mechanics of the chorioamnion membrane with an emphasis on fracture properties. Ann NY Acad Sci. 2007;1101(1):166–185.
  • Richardson LS, Vargas G, Brown T, et al. Discovery and characterization of human amniochorionic membrane microfractures. Am J Pathol. 2017;187(12):2821–2830.
  • Millar LK, Boesche MH, Yamamoto SY, et al. A relaxin-mediated pathway to preterm premature rupture of the fetal membranes that is independent of infection. Am J Obstet Gynecol. 1998;179(1):126–134.
  • Qin X, Garibay-Tupas J, Chua PK, et al. An autocrine/paracrine role of human decidual relaxin. I. Interstitial collagenase (matrix metalloproteinase-1) and tissue plasminogen activator. Biol Reprod. 1997;56(4):800–811.
  • Bryant-Greenwood GD. The extracellular matrix of the human fetal membranes: Structure and function. Placenta. 1998;19(1):1–11.
  • Moron AF, Athanasiou A, Barbosa M, et al. Amniotic fluid lactic acid and matrix metalloproteinase-8 levels at the time of fetal surgery for a spine defect: association with subsequent preterm prelabour rupture of membranes. BJOG. 2018;125(10):1288–1292.
  • Gratacós E, Sanin-Blair J, Lewi L, et al. A histological study of fetoscopic membrane defects to document membrane healing. Placenta. 2006;27(4–5):452–456.
  • Langston C, Kaplan C, Macpherson T, et al. Practice guideline for examination of the placenta: developed by the Pathology Practice Guideline Development Task Force of the College of American pathologists. Arch Pathol Lab Med. 1997;121(5):449–476.
  • Carvalho N S, Moron A F, Menon R, et al. Histological evidence of reparative activity in chorioamniotic membrane following open fetal surgery for myelomeningocele. Experimental and Therapeutic Medicine. 2017;14(4):3732–3736. doi:https://doi.org/10.3892/etm.2017.4976.
  • Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92(8):827–839.
  • Romero-Valdovinos M, Bobadilla-Sandoval N, Flisser A, et al. The epithelial mesenchymal transition process may contribute to the pathogenesis of amniotic band syndrome. Med Hypotheses. 2014;83(3):306–311.
  • Vempati P, Karagiannis ED, Popel AS. A biochemical model of matrix metalloproteinase 9 activation and inhibition. J Biol Chem. 2007;282(52):37585–37596.
  • Fortunato SJ, Menon R, Lombardi SJ. Presence of four tissue inhibitors of matrix metalloproteinases (TIMP-1, -2, -3 and -4) in human fetal membranes. Am J Reprod Immunol. 1998;40(6):395–400.
  • Athayde N, Edwin SS, Romero R, et al. A role for matrix metalloproteinase-9 in spontaneous rupture of the fetal membranes. Am J Obstet Gynecol. 1998;179(5):1248–1253.
  • Maymon E, Romero R, Pacora P, et al. Evidence for the participation of interstitial collagenase (matrix metalloproteinase 1) in preterm premature rupture of membranes. Am J Obstet Gynecol. 2000;183(4):914–920.
  • Weiss A, Goldman S, Shalev E. The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front Biosci. 2007;12(1):649–659.
  • Papanna R, Mann LK, Moise KJ, et al. Histologic changes of the fetal membranes after fetoscopic laser surgery for twin-twin transfusion syndrome. Pediatr Res. 2015;78(3):247–255.
  • Barrett DW, David AL, Thrasivoulou C, et al. Connexin 43 is overexpressed in human fetal membrane defects after fetoscopic surgery. Prenat Diagn. 2016;36(10):942–952.
  • Papanna R, Mann LK, Tseng SCG, et al. Cryopreserved human amniotic membrane and a bioinspired underwater adhesive to seal and promote healing of iatrogenic fetal membrane defect sites. Placenta. 2015;36(8):888–894.
  • Devlieger R, Gratacós E, Verbist L, et al. Gestational age-dependent repair kinetics of microsurgical defects in monolayers of human amniocytes. Gynecol Obstet Invest. 2010;69(1):62–66.
  • Dhital B, Gul-E-Noor F, Downing KT, et al. Pregnancy-induced dynamical and structural changes of reproductive tract collagen. Biophys J. 2016;111(1):57–68.
  • Woessner JF, Brewer TH. Formation and breakdown of collagen and elastin in the human uterus during pregnancy and post-partum involution. Biochem J. 1963;89(1):75–82.
  • Kabagambe SK, Jensen GW, Chen YJ, et al. Fetal surgery for myelomeningocele: a systematic review and meta-analysis of outcomes in fetoscopic versus open repair. Fetal Diagn Ther. 2018;43(3):161–174.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.